ArticleClinical and experimental dermatology2022

Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.

A Ruggiero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.